#Pharmacists

Why Community Pharmacies May Be the Key to Staying on GLP-1 Medications

Why Community Pharmacies May Be the Key to Staying on GLP-1 Medications

A new Milken Institute report, released alongside survey research, argues that community pharmacies can play a central role in helping patients stay on GLP-1 medications. Real-world data cited in the report indicates that roughly 47% to 68% of people stop treatment within the first year, and nearly three in four GLP-1 users say more time with a pharmacist would improve their experience and results. The report points to side effects during dose changes, prior authorization hurdles, and out-of-pocket costs as common reasons patients abandon therapy. It also highlights pharmacy-led check-ins, navigation support, and clearer reimbursement pathways as practical steps that could help patients and pharmacy teams stay on track over the long term.